Blood thinner shows promise for kids with dangerous clots
NCT ID NCT07618988
First seen Jun 12, 2026 · Last updated Jun 16, 2026 · Updated 1 time
Summary
This study tested the safety and effectiveness of the blood thinner rivaroxaban in 60 children aged 6 months to 18 years who had deep vein clots. The main goal was to see if the drug helped clear the clots after 3 months of treatment. The results will help doctors decide if rivaroxaban is a good option for treating clots in children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC VENOUS THROMBOEMBOLISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ain Shams University Children's Hospital
Cairo, 11566, Egypt
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.